CLOVER HEALTH INVESTMENTS CO (CLOV) Stock Price, Quote, News and Overview
NASDAQ:CLOV - Nasdaq - US18914F1030 - Common Stock - Currency: USD
CLOV Quote, Performance and Key Statistics
2.18
-0.03 (-1.36%)
The current stock price of CLOV is 2.18 USD. In the past month the price decreased by -25.34%. In the past year, price increased by 17.2%.
CLOV Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| UNH | UNITEDHEALTH GROUP INC | 9.94 | 227.59B | ||
| ELV | ELEVANCE HEALTH INC | 8.9 | 66.20B | ||
| HUM | HUMANA INC | 13.43 | 32.19B | ||
| CNC | CENTENE CORP | 4.96 | 12.57B | ||
| MOH | MOLINA HEALTHCARE INC | 6.94 | 8.50B | ||
| HQY | HEALTHEQUITY INC | 28.2 | 8.05B | ||
| ALHC | ALIGNMENT HEALTHCARE INC | N/A | 2.87B | ||
| PGNY | PROGYNY INC | 25.97 | 1.96B | ||
| NEUE | NEUEHEALTH INC | N/A | 60.01M |
Related stock screener links
About CLOV
Company Profile
Clover Health Investments Corp. is a physician enablement technology company that provides Medicare Advantage plans in the United States. The company is headquartered in Jersey City, New Jersey and currently employs 570 full-time employees. The company went IPO on 2020-06-12. The firm is focused on bringing access to healthcare to everyone on Medicare. This includes a health equity-based focus on seniors, who have historically lacked access to affordable healthcare. Its software platform, Clover Assistant, is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. The Company, through its Insurance segment, provides Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans to Medicare Advantage (MA) members in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. For healthcare providers outside its MA plan, it focuses on extending the benefits of its data-driven technology platform to a wider audience via its subsidiary, Counterpart Health, Inc.
Company Info
CLOVER HEALTH INVESTMENTS CO
30 Montgomery Street
Jersey City NEW JERSEY 37067 US
CEO: Vivek Garipalli
Employees: 552
Phone: 12014322133
CLOVER HEALTH INVESTMENTS CO / CLOV FAQ
What is the stock price of CLOVER HEALTH INVESTMENTS CO today?
The current stock price of CLOV is 2.18 USD. The price decreased by -1.36% in the last trading session.
What is the ticker symbol for CLOVER HEALTH INVESTMENTS CO stock?
The exchange symbol of CLOVER HEALTH INVESTMENTS CO is CLOV and it is listed on the Nasdaq exchange.
On which exchange is CLOV stock listed?
CLOV stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for CLOVER HEALTH INVESTMENTS CO stock?
11 analysts have analysed CLOV and the average price target is 4.18 USD. This implies a price increase of 91.83% is expected in the next year compared to the current price of 2.18. Check the CLOVER HEALTH INVESTMENTS CO stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is CLOVER HEALTH INVESTMENTS CO worth?
CLOVER HEALTH INVESTMENTS CO (CLOV) has a market capitalization of 1.11B USD. This makes CLOV a Small Cap stock.
How many employees does CLOVER HEALTH INVESTMENTS CO have?
CLOVER HEALTH INVESTMENTS CO (CLOV) currently has 552 employees.
What are the support and resistance levels for CLOVER HEALTH INVESTMENTS CO (CLOV) stock?
CLOVER HEALTH INVESTMENTS CO (CLOV) has a resistance level at 2.88. Check the full technical report for a detailed analysis of CLOV support and resistance levels.
Is CLOVER HEALTH INVESTMENTS CO (CLOV) expected to grow?
The Revenue of CLOVER HEALTH INVESTMENTS CO (CLOV) is expected to grow by 22.74% in the next year. Check the estimates tab for more information on the CLOV EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy CLOVER HEALTH INVESTMENTS CO (CLOV) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of CLOV, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of CLOV, evaluating the profitability, health, valuation and growth aspects
- CLOVER HEALTH INVESTMENTS CO (CLOV) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- CLOVER HEALTH INVESTMENTS CO (CLOV) Sales and EPS estimates to see what analysts future expectations are.
- CLOVER HEALTH INVESTMENTS CO (CLOV) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- CLOVER HEALTH INVESTMENTS CO (CLOV) Insider and Institutional Ownership to learn about the owners and their transactions.
- CLOVER HEALTH INVESTMENTS CO (CLOV) Stock Chart to make your own analysis
- CLOVER HEALTH INVESTMENTS CO (CLOV) Latest news and press-releases to stay up to date.
Does CLOVER HEALTH INVESTMENTS CO (CLOV) stock pay dividends?
CLOV does not pay a dividend.
When does CLOVER HEALTH INVESTMENTS CO (CLOV) report earnings?
CLOVER HEALTH INVESTMENTS CO (CLOV) will report earnings on 2025-11-04, after the market close.
What is the Price/Earnings (PE) ratio of CLOVER HEALTH INVESTMENTS CO (CLOV)?
CLOVER HEALTH INVESTMENTS CO (CLOV) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.03).
What is the Short Interest ratio of CLOVER HEALTH INVESTMENTS CO (CLOV) stock?
The outstanding short interest for CLOVER HEALTH INVESTMENTS CO (CLOV) is 9.04% of its float. Check the ownership tab for more information on the CLOV short interest.
CLOV Technical Analysis
CLOV Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to CLOV. CLOV scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
CLOV Financial Highlights
Over the last trailing twelve months CLOV reported a non-GAAP Earnings per Share(EPS) of -0.03. The EPS increased by 88.46% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -4.3% | ||
| ROE | -7.47% | ||
| Debt/Equity | 0 |
CLOV Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 76% to CLOV. The Buy consensus is the average rating of analysts ratings from 11 analysts.
For the next year, analysts expect an EPS growth of -41.67% and a revenue growth 22.74% for CLOV